Oncopeptides AB (STU:OND) YoY Rev. per Sh. Growth : 20.00% (As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Oncopeptides AB YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Oncopeptides AB's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2025 was 20.00%.

Oncopeptides AB's Revenue per Share for the three months ended in Mar. 2025 was €0.01.

Oncopeptides AB YoY Rev. per Sh. Growth Historical Data

The historical data trend for Oncopeptides AB's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncopeptides AB YoY Rev. per Sh. Growth Chart

Oncopeptides AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY Rev. per Sh. Growth

Get a 7-Day Free Trial

-93.58

400.00

-51.43

Oncopeptides AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
YoY Rev. per Sh. Growth	Get a 7-Day Free Trial															400.00	-79.17	33.33	-20.00	20.00

Oncopeptides AB YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Oncopeptides AB's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY Rev. per Sh. Growth (A: Dec. 2024 )
=	(Revenue per Share (A: Dec. 2024 )	-	Revenue per Share (A: Dec. 2023 ))	/	\| Revenue per Share (A: Dec. 2023 ) \|
=	(0.017	-	0.035)	/	\| 0.035 \|
=	-51.43 %

Oncopeptides AB's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2025 is calculated as:

	YoY Rev. per Sh. Growth (Q: Mar. 2025 )
=	(Revenue per Share (Q: Mar. 2025 )	-	Revenue per Share (Q: Mar. 2024 ))	/	\| Revenue per Share (Q: Mar. 2024 )) \|
=	(0.006	-	0.005)	/	\| 0.005 \|
=	20.00 %

Oncopeptides AB YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Oncopeptides AB's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncopeptides AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncopeptides AB (STU:OND) » Definitions » YoY Rev. per Sh. Growth

Comparable Companies

Traded in Other Exchanges

ONCO:Sweden 0RN4:UK

Address

Vastra Tradgardsgatan 15, Stockholm, SWE, SE-111 53

Website

https://www.oncopeptides.com

Oncopeptides AB is a biotech company focused on the research, development, and commercialization of therapies for difficult-to-treat hematological diseases. The company uses its proprietary Peptide Drug Conjugate (PDC) to develop compounds that rapidly and selectively deliver cytotoxic agents into cancer cells. It has focused on the development of the product candidate Melflufen (Pepaxti), a peptide-conjugated alkylator, belonging to a new class of drugs called Peptidase Enhanced Compounds. Melflufen is intended as an effective treatment for hematological cancers and in particular multiple myeloma.